insights_auto
Outlook: 60.9% bullish·0.0% bearish
Go to analysischevron_right
BNTX:NASDAQ
BioNTech SE - ADR
$87.40
arrow_downward
-0.13%(-0.11) 1D
Nov 9, 10:21:56 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BNTX...
Open
$87.76
High
$88.00
Low
$86.56
Mkt. cap
21.67B
Avg. vol.
1.07M
Volume
116.47K
52-wk high
$123.98
52-wk low
$79.52
EPS
-$6.53
Beta
1.26
Shares outstanding
251.20M
No. of employees
8K
Open
$87.76
High
$88.00
Low
$86.56
Mkt. cap
21.67B
Avg. vol.
1.07M
Volume
116.47K
52-wk high
$123.98
52-wk low
$79.52
EPS
-$6.53
Beta
1.26
Shares outstanding
251.20M
No. of employees
8K
News stories
From web sources and news partners
GuruFocus
·
1 hour ago
BNTX Maintained by HC Wainwright & Co. -- Price Target Lowered t
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR